ReWrite

ReWrite is a biotechnology company based in Leuven, Belgium, specializing in induced pluripotent stem cell (iPSC) technologies and genome editing. The company supports academic and industry researchers by generating high-quality iPSC lines, performing precise CRISPR-based genome engineering, and developing human cellular disease models.

ReWrite provides customized cell engineering services with rigorous quality control to accelerate biomedical research and drug discovery.

Future services and products include ready-to-use iPSC disease models, genome-edited reference cell lines, and stem cell–based platforms for functional genomics and therapeutic development.